These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30223241)

  • 1. A circular toxicity approach to isoprostanes: From markers of oxidative stress, to epidemiological warning systems and agents of aquatic toxicity.
    Pais RT; Sousa ACA; Pastorinho MR
    Environ Pollut; 2018 Dec; 243(Pt A):654-660. PubMed ID: 30223241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo.
    Yin H
    Biofactors; 2008; 34(2):109-24. PubMed ID: 19706977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into oxidative stress: the isoprostanes.
    Montuschi P; Barnes P; Roberts LJ
    Curr Med Chem; 2007; 14(6):703-17. PubMed ID: 17346157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.
    Musiek ES; Breeding RS; Milne GL; Zanoni G; Morrow JD; McLaughlin B
    J Neurochem; 2006 Jun; 97(5):1301-13. PubMed ID: 16638022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of contagious toxicity? Isoprostanes as potential emerging contaminants of concern.
    Gaw S; Glover CN
    Sci Total Environ; 2016 Aug; 560-561():295-8. PubMed ID: 27102276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of isoprostanes as markers of oxidative stress in neuronal tissue.
    Milatovic D; Aschner M
    Curr Protoc Toxicol; 2009 Feb; Chapter 12(Supplement 39):Unit12.14. PubMed ID: 20191108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoprostanes-biomarkers of lipid peroxidation: their utility in evaluating oxidative stress and analysis.
    Janicka M; Kot-Wasik A; Kot J; Namieśnik J
    Int J Mol Sci; 2010 Nov; 11(11):4631-59. PubMed ID: 21151461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The isoprostanes: unique bioactive products of lipid peroxidation.
    Morrow JD; Roberts LJ
    Prog Lipid Res; 1997 Mar; 36(1):1-21. PubMed ID: 9373618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.
    Musiek ES; Yin H; Milne GL; Morrow JD
    Lipids; 2005 Oct; 40(10):987-94. PubMed ID: 16382569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F2-isoprostanes are not just markers of oxidative stress.
    Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C
    Free Radic Biol Med; 2008 Feb; 44(3):247-56. PubMed ID: 17997380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The isoprostanes--25 years later.
    Milne GL; Dai Q; Roberts LJ
    Biochim Biophys Acta; 2015 Apr; 1851(4):433-45. PubMed ID: 25449649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.
    Roberts LJ; Morrow JD
    Free Radic Biol Med; 2000 Feb; 28(4):505-13. PubMed ID: 10719231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophilic cyclopentenone isoprostanes in neurodegeneration.
    Musiek ES; McLaughlin B; Morrow JD
    J Mol Neurosci; 2007 Sep; 33(1):80-6. PubMed ID: 17901550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid peroxidation products as oxidative stress biomarkers.
    Niki E
    Biofactors; 2008; 34(2):171-80. PubMed ID: 19706982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.
    Milne GL; Yin H; Brooks JD; Sanchez S; Jackson Roberts L; Morrow JD
    Methods Enzymol; 2007; 433():113-26. PubMed ID: 17954231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and urinary F
    Granick M; Leuin AS; Trepanier LA
    J Feline Med Surg; 2021 Aug; 23(8):692-699. PubMed ID: 33146574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are isoprostanes a clinical marker for antioxidant drug investigation?
    Souvignet C; Cracowski JL; Stanke-Labesque F; Bessard G
    Fundam Clin Pharmacol; 2000; 14(1):1-10. PubMed ID: 10681068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress.
    Morrow JD; Roberts LJ
    Methods Enzymol; 1999; 300():3-12. PubMed ID: 9919502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Today's oxidative stress markers.
    Czerska M; Mikołajewska K; Zieliński M; Gromadzińska J; Wąsowicz W
    Med Pr; 2015; 66(3):393-405. PubMed ID: 26325052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry.
    Yen HC; Wei HJ; Lin CL
    Free Radic Res; 2015; 49(7):861-80. PubMed ID: 25812589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.